BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22124881)

  • 1. Estrogen plus estrogen receptor antagonists alter mineral production by osteoblasts in vitro.
    Brennan O; O'Brien FJ; McNamara LM
    Horm Metab Res; 2012 Jan; 44(1):47-53. PubMed ID: 22124881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The marine-derived, multi-mineral formula, Aquamin, enhances mineralisation of osteoblast cells in vitro.
    O'Gorman DM; Tierney CM; Brennan O; O'Brien FJ
    Phytother Res; 2012 Mar; 26(3):375-80. PubMed ID: 21751268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen withdrawal from osteoblasts and osteocytes causes increased mineralization and apoptosis.
    Brennan MÁ; Haugh MG; O'Brien FJ; McNamara LM
    Horm Metab Res; 2014 Jul; 46(8):537-45. PubMed ID: 24446157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
    Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
    J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct action of naturally occurring estrogen metabolites on human osteoblastic cells.
    Robinson JA; Waters KM; Turner RT; Spelsberg TC
    J Bone Miner Res; 2000 Mar; 15(3):499-506. PubMed ID: 10750564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
    Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
    J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
    De Wilde A; Lieberherr M; Colin C; Pointillart A
    J Cell Physiol; 2004 Aug; 200(2):253-62. PubMed ID: 15174095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor and Wnt signaling interact to regulate early gene expression in response to mechanical strain in osteoblastic cells.
    Liedert A; Wagner L; Seefried L; Ebert R; Jakob F; Ignatius A
    Biochem Biophys Res Commun; 2010 Apr; 394(3):755-9. PubMed ID: 20227388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites.
    Enríquez J; Lemus AE; Chimal-Monroy J; Arzate H; García GA; Herrero B; Larrea F; Pérez-Palacios G
    J Endocrinol; 2007 Jun; 193(3):493-504. PubMed ID: 17535886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O; Yamagishi T; Hanada K; Kawashima H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation.
    Bonewald LF; Harris SE; Rosser J; Dallas MR; Dallas SL; Camacho NP; Boyan B; Boskey A
    Calcif Tissue Int; 2003 May; 72(5):537-47. PubMed ID: 12724828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.
    Ogawa N; Yamaguchi T; Yano S; Yamauchi M; Yamamoto M; Sugimoto T
    Horm Metab Res; 2007 Dec; 39(12):871-5. PubMed ID: 17960513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of fulvestrant, an estrogen receptor antagonist, on the proliferation, differentiation and mineralization of osteoprecursor cells.
    Park JB
    Mol Med Rep; 2013 Feb; 7(2):555-8. PubMed ID: 23179494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanolic extract of Actaea racemosa (black cohosh) potentiates bone nodule formation in MC3T3-E1 preosteoblast cells.
    Chan BY; Lau KS; Jiang B; Kennelly EJ; Kronenberg F; Kung AW
    Bone; 2008 Sep; 43(3):567-73. PubMed ID: 18555764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts.
    Sasaki-Iwaoka H; Maruyama K; Endoh H; Komori T; Kato S; Kawashima H
    J Bone Miner Res; 1999 Feb; 14(2):248-55. PubMed ID: 9933479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
    McCauley LK; Koh AJ; Beecher CA; Cui Y; Decker JD; Franceschi RT
    J Bone Miner Res; 1995 Aug; 10(8):1243-55. PubMed ID: 8585429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of p53 expression and function by estrogen in osteoblasts.
    Bovenkerk S; Lanciloti N; Chandar N
    Calcif Tissue Int; 2003 Sep; 73(3):274-80. PubMed ID: 14667141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.